Case Report: Cymbalta Withdrawal Persists for 10 Months

In January, 2014, an article published in The Journal of Neuropsychiatry and Clinical Neurosciences titled “Long-Term Duloxetine Withdrawal Syndrome and Management in a Depressed Patient” reported on a depressed patient who used Cymbalta (duloxetine), discontinued the drug, and faced long-term withdrawal symptoms. After using Cymbalta (60mg/day) for one year, the patient, called “Miss B” in

Xarelto Lawsuit Information

WARNING: Xarelto Linked to Fatal Internal Bleeding, No Reversal Agent Recently, the anticoagulant drug Xarelto (rivaroxaban) has come under increased scrutiny by both the United States Food and Drug Administration and medical professionals alike, citing an increased risk for internal bleeding.  Unfortunately, there is as yet no reversal agent for the drug. Due to inadequate

Surgical Removals of Mirena IUD Increasing

A number of lawsuits have arisen due to the complications caused by the use of intrauterine contraceptive devices (IUDs).  It has been shown that with the increase in popularity of IUDs, there has been a notable rise of cases where migration of the devices leads to a need for corrective surgery for the removal of

From Conservative Court to Activist Court in One Decision

When is a conservative court not a conservative court?  When it expands tort liability, apparently: Last month, in Wyeth v. Weeks, the Alabama Supreme Court adopted an aggressive new theory of tort liability that threatens to return Alabama to a litigation era so hostile to business and industry that the state was dubbed “Tort Hell.” In Weeks,

DePuy Engineer Explains Flaw in Internal Testing of ASR Hip

The New York Times reports on the interesting information being revealed in the first DePuy ASR hip trial: Separately, a DePuy engineer, Graham Isaac, testified on Thursday that before selling the A.S.R., the company only tested its performance on laboratory equipment at one angle of implantation. Depending on the surgical technique and a patient’s build,

FDA May Require More Information from Metal-on-Metal Hip Makers

Once again, the FDA arrives late to the party: Jan 17 (Reuters) – The U.S. Food and Drug Administration has issued a proposal calling on companies that make all-metal hip replacements to provide additional information proving they are safe and effective before being allowed to continue selling them. The move follows years of concern within

Yaz Lawyer Blog Has Been Updated and Redesigned

My Yaz lawyer blog,, had gotten a little long in the tooth.  So I updated it and added some fresh content for October 2012 regarding Yaz lawsuits and Yaz settlements.  Here’s a taste: As of October of 2012, Bayer has settled close to 2,000 Yaz lawsuits for close to $500 million dollars. Bayer has

Topamax Linked to Cleft Lips

In early March of 2011, the FDA strengthened the warning label on Topamax (generic name: Topiramate) due to an association between Topamax use and birth defects.  Currently, Topamax is most strongly associated with oral birth defects, such as cleft lips and cleft palates. Cleft lips are fairly common birth defects in which the upper lip